54aafc79868f4b00075cb3a1_logo.jpg
Canbiola Files 14C Informational Statement to Satisfy One Criteria for a Potential Nasdaq Listing
18 nov. 2019 07h00 HE | Canbiola, Inc.
Reverse Stock Split to Meet Nasdaq Stock Price Threshold has Board and Majority Shareholder Support HICKSVILLE, NY, Nov. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Canbiola, Inc. (OTCQB:...
logo.jpg
Innate Pharma announces the exercise in full of the option granted to the underwriters of its global offering and Nasdaq global select market listing to purchase 1,875,000 additional ADSs
18 oct. 2019 10h00 HE | INNATE PHARMA
Marseille, France, October 17, 2019, 8:30 AM CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...
logo.jpg
Innate Pharma announces trading halt of its ordinary shares on Euronext Paris
17 oct. 2019 02h30 HE | INNATE PHARMA
Marseille, France, October 17, 2019, 8:30 AM CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...
logo.jpg
Innate Pharma announces the pricing of its initial public offering on the Nasdaq global select market
17 oct. 2019 01h00 HE | INNATE PHARMA
Marseille, France, October 17, 2019, 7:00 AM CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate Pharma” or the “Company”), a French biotechnology company focused on...
logo.jpg
Innate Pharma announces launch of proposed global offering and Nasdaq listing
07 oct. 2019 01h00 HE | INNATE PHARMA
Marseille, France, October 7, 2019, 7:00 CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...
Attis.png
Attis Provides an Update on Status of Nasdaq Listing
23 août 2019 17h00 HE | Attis Industries, Inc.
Attis to Continue Appeal of Staff Determination Regarding Delinquent Reports MILTON, GA, Aug. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Attis Industries Inc. (NASDAQ: ATIS) (the “Company” or...
Attis.png
Attis Industries Reverse Splits Stock 1-for-8 to Maintain Nasdaq Listing
15 mars 2019 18h18 HE | Attis Industries, Inc.
MILTON, GA, March 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Attis Industries, Inc. (NASDAQ: ATIS) (the “Company” or “Attis”), a diversified innovation and technology holding company, today...